Moreover, adoptive transfer of both mesothelin-redirected CAR-T products into SKOV3-based xenograft mouse models resulted in remarkable tumor regression, as compared with the control T cell group, with the A2aR-disrupted CAR-Ts mediating more pronounced tumoricidal reactions (148). The gene discussed is ADORA2A; the disease is neoplasm.